Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Elevation Oncology
Biotech
Elevation faces activist investor demands to wind down
Elevation Oncology has become the second biotech this week to face calls from an activist investor to wind down.
James Waldron
Apr 17, 2025 10:00am
Former FDA deputy joins AI biotech's board—Chutes & Ladders
Mar 21, 2025 8:30am
Elevation drops sole clinical-stage ADC, lays off 70% of staff
Mar 20, 2025 10:20am
Elevation lifts HER3 ADC toward clinic with $368M Synaffix deal
Dec 12, 2024 9:19am
Former BMS R&D chief Vessey jumping to Flagship—Chutes & Ladders
Jul 14, 2023 9:30am
Century, Elevation to cut assets, staff; Nabriva winds down
Jan 6, 2023 10:40am
